Bellicum offloads cell therapy plant in switch to outsourced production
Bellicum sells cell therapy manufacturing plant to MD Anderson Cancer Center, strikes master service agreement.
Archives for January 28, 2020
Lonza poised to add 600 staff as investment peak continues into 2020
Lonza set to recruit 600 new staff globally at biopharma unit as spending spree continues.
Krystal Biotech continues internal buildout with second facility
The gene therapy company breaks ground on a backup facility ahead of the potential commercial launch of its lead therapy, B-VEC.